These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29110244)

  • 21. Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial.
    Ruban A; Miras AD; Glaysher MA; Goldstone AP; Prechtl CG; Johnson N; Chhina N; Al-Najim W; Aldhwayan M; Klimowska-Nassar N; Smith C; Lord J; Li JV; Flores L; Al-Lababidi M; Dimitriadis GK; Patel M; Moore M; Chahal H; Ahmed AR; Cousins J; Aldubaikhi G; Glover B; Falaschetti E; Ashrafian H; Roux CWL; Darzi A; Byrne JP; Teare JP
    Ann Surg; 2022 Mar; 275(3):440-447. PubMed ID: 34647708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of glucometric 'dynamical' variables on duodenal-jejunal bypass liner (DJBL) anthropometric and metabolic outcomes.
    Colás A; Varela M; Mraz M; Novak D; Cuesta-Frau D; Vigil L; Benes M; Pelikanova T; Haluzik M; Burda V; Vargas B
    Diabetes Metab Res Rev; 2020 May; 36(4):e3287. PubMed ID: 31916665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duodenal-Jejunal Bypass Liner (DJBL) Improves Cardiovascular Risk Biomarkers and Predicted 4-Year Risk of Major CV Events in Patients with Type 2 Diabetes and Metabolic Syndrome.
    Roehlen N; Laubner K; Bettinger D; Schwacha H; Hilger H; Koenig C; Grueninger D; Krebs A; Seufert J
    Obes Surg; 2020 Apr; 30(4):1200-1210. PubMed ID: 31898040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained weight loss after duodenal-jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m
    Boonchaya-Anant P; Bueter M; Gubler C; Gerber PA
    Clin Obes; 2023 Feb; 13(1):e12561. PubMed ID: 36239531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients.
    Forner PM; Ramacciotti T; Farey JE; Lord RV
    Obes Surg; 2017 Dec; 27(12):3306-3313. PubMed ID: 29018990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes.
    Rodriguez L; Reyes E; Fagalde P; Oltra MS; Saba J; Aylwin CG; Prieto C; Ramos A; Galvao M; Gersin KS; Sorli C
    Diabetes Technol Ther; 2009 Nov; 11(11):725-32. PubMed ID: 19905889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Early Reimplantation of the Duodenal-Jejunal Bypass Liner Viable?
    Leventi E; Günthert SJ; Stier C; Staikov P; Stein J; Farrag K
    Obes Surg; 2019 May; 29(5):1690-1693. PubMed ID: 30826914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Duodenal-Jejunal Bypass Liner (EndoBarrier®) on Gastric Emptying in Obese and Type 2 Diabetic Patients.
    de Moura EG; Lopes GS; Martins BC; Orso IR; Coutinho AM; de Oliveira SL; Sakai P; Galvão-Neto Mdos P; Santo MA; Sapienza MT; Cecconello I; Buchpiguel CA
    Obes Surg; 2015 Sep; 25(9):1618-25. PubMed ID: 25691349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute pancreatitis as an adverse event in patients with the duodenal-jejunal bypass liner.
    Betzel B; Homan J; Aarts E; Janssen I; Spanier M; Wahab P; Groenen M; Berends F
    Endoscopy; 2015 Nov; 47(11):1050-3. PubMed ID: 26021308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of duodenal-jejunal bypass liner (DJBL) on NAFLD in patients with obesity and type 2 diabetes mellitus.
    Roehlen N; Laubner K; Nicolaus L; Schwacha H; Bettinger D; Krebs A; Thimme R; Seufert J
    Nutrition; 2022; 103-104():111806. PubMed ID: 36115281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders.
    Stratmann B; Krepak Y; Schiffer E; Jarick I; Hauber M; Lee-Barkey YH; Fischer M; Tschoepe D
    Horm Metab Res; 2016 Sep; 48(10):630-637. PubMed ID: 27589345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of the endoscopic duodenal-jejunal bypass liner prototype in severe or morbidly obese subjects implanted for up to 3 years.
    Quezada N; Muñoz R; Morelli C; Turiel D; Hernández J; Pimentel F; Escalona A
    Surg Endosc; 2018 Jan; 32(1):260-267. PubMed ID: 28664427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relevant Weight Reduction and Reversed Metabolic Co-morbidities Can Be Achieved by Duodenojejunal Bypass Liner in Adolescents with Morbid Obesity.
    Homan M; Kovač J; Orel R; Battelino T; Kotnik P
    Obes Surg; 2020 Mar; 30(3):1001-1010. PubMed ID: 31758471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duodenal-jejunal bypass liner to treat type 2 diabetes mellitus in morbidly obese patients.
    Muñoz R; Escalona A
    Curr Cardiol Rep; 2014 Mar; 16(3):454. PubMed ID: 24570355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse Events of the Duodenal-Jejunal Bypass Liner: a Systematic Review.
    Betzel B; Drenth JPH; Siersema PD
    Obes Surg; 2018 Nov; 28(11):3669-3677. PubMed ID: 30121857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effects of proximal small bowel exclusion by duodenal-jejunal bypass liner on weight reduction and glycemic control in diabetic patients.
    Deutsch L; Ben Haim L; Sofer Y; Gluck N; Santo E; Fishman S
    Surg Obes Relat Dis; 2018 Oct; 14(10):1561-1569. PubMed ID: 30449512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.
    de Jonge C; Rensen SS; Verdam FJ; Vincent RP; Bloom SR; Buurman WA; le Roux CW; Schaper NC; Bouvy ND; Greve JW
    Obes Surg; 2013 Sep; 23(9):1354-60. PubMed ID: 23526068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner.
    de Moura EG; Martins BC; Lopes GS; Orso IR; de Oliveira SL; Galvão Neto MP; Santo MA; Sakai P; Ramos AC; Garrido Júnior AB; Mancini MC; Halpern A; Cecconello I
    Diabetes Technol Ther; 2012 Feb; 14(2):183-9. PubMed ID: 21932999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The duodenal-jejunal bypass liner for the treatment of type 2 diabetes mellitus and/or obesity: a systematic review.
    Zechmeister-Koss I; Huić M; Fischer S;
    Obes Surg; 2014 Feb; 24(2):310-23. PubMed ID: 24293185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study of the duodenal-jejunal bypass liner in low body mass index type 2 diabetes.
    Cohen RV; Neto MG; Correa JL; Sakai P; Martins B; Schiavon CA; Petry T; Salles JE; Mamedio C; Sorli C
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E279-82. PubMed ID: 23337729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.